Last 12 months
Inside the activity.
0 purchase rows · 3 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 19, 2019 Filed Mar 21, 2019 20:42 UTC |
MCNABB FREDERICK WILLIAM IIIDirector
|
GrantCommon Stock | 4 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-020778 · doc4.xml · nonDerivative · entry 1 MCNABB FREDERICK WILLIAM III · CIK 0001731814 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,113 F1 · shares: Represents dividend equivalents paid on vested deferred stock units. The dividend equivalents are immediately vested and are subject to the same terms as the underlying deferred stock units. Read SEC document |
| March 19, 2019 Filed Mar 21, 2019 20:43 UTC |
MONTGOMERY RICE VALERIE MDDirector
|
GrantCommon Stock | 4 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-020780 · doc4.xml · nonDerivative · entry 1 MONTGOMERY RICE VALERIE MD · CIK 0001714561 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,106 F1 · shares: Represents dividend equivalents paid on vested deferred stock units. The dividend equivalents are immediately vested but must be retained by the director until the director's completion of service on the Board. Read SEC document |
| March 19, 2019 Filed Mar 21, 2019 20:43 UTC |
Nelson Steven HEVP & CEO, UnitedHealthcare
|
GrantCommon Stock | 60.871 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-020781 · doc4.xml · nonDerivative · entry 1 Nelson Steven H · CIK 0001320490 · EVP & CEO, UnitedHealthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,394.075 F1 · shares: Represents dividend equivalents paid on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if such units do not vest. Read SEC document |
| March 19, 2019 Filed Mar 21, 2019 20:44 UTC |
RENWICK GLENN MDirector
|
GrantCommon Stock | 156 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-020782 · doc4.xml · nonDerivative · entry 1 RENWICK GLENN M · CIK 0001198119 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,669 F1 · shares: Represents dividend equivalents paid on vested deferred stock units. The dividend equivalents are immediately vested and are subject to the same terms as the underlying deferred stock units. Read SEC document |
| March 19, 2019 Filed Mar 21, 2019 20:44 UTC |
REX JOHN FEVP Chief Financial Officer
|
GrantCommon Stock | 73.822 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-020783 · doc4.xml · nonDerivative · entry 1 REX JOHN F · CIK 0001676672 · EVP Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,100.124 F1 · shares: Represents dividend equivalents paid on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if such units do not vest. Read SEC document |
| March 19, 2019 Filed Mar 21, 2019 20:45 UTC |
ROOS THOMAS EChief Accounting Officer
|
GrantCommon Stock | 51.142 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-020784 · doc4.xml · nonDerivative · entry 1 ROOS THOMAS E · CIK 0001651737 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,879.809 F1 · shares: Represents dividend equivalents paid on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if such units do not vest. Read SEC document |
| March 19, 2019 Filed Mar 21, 2019 20:45 UTC |
SHORT MARIANNE DEVP & Chief Legal Officer
|
GrantCommon Stock | 74.582 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-020786 · doc4.xml · nonDerivative · entry 1 SHORT MARIANNE D · CIK 0001565456 · EVP & Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,007.745 F1 · shares: Represents dividend equivalents paid on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if such units do not vest. Read SEC document |
| March 19, 2019 Filed Mar 21, 2019 20:46 UTC |
WICHMANN DAVID SDirector · Chief Executive Officer
|
GrantCommon Stock | 122.361 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-020787 · doc4.xml · nonDerivative · entry 1 WICHMANN DAVID S · CIK 0001268489 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 884,366.882 F1 · shares: Represents dividend equivalents paid on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if such units do not vest. Read SEC document |
| March 19, 2019 Filed Mar 21, 2019 20:46 UTC |
WILENSKY GAIL RDirector
|
GrantCommon Stock | 76 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-020788 · doc4.xml · nonDerivative · entry 1 WILENSKY GAIL R · CIK 0001018538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,732 F1 · shares: Represents dividend equivalents paid on vested deferred stock units. The dividend equivalents are immediately vested and are subject to the same terms as the underlying deferred stock units. Read SEC document |
| March 19, 2019 Filed Mar 21, 2019 20:46 UTC |
WILSON D ELLENEVP & Chief HR Officer
|
GrantCommon Stock | 68.296 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-020790 · doc4.xml · nonDerivative · entry 1 WILSON D ELLEN · CIK 0001633390 · EVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,554.144 F1 · shares: Represents dividend equivalents paid on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if such units do not vest. Read SEC document |
| March 19, 2019 Filed Mar 21, 2019 20:47 UTC |
WITTY ANDREWEVP & CEO, Optum
|
GrantCommon Stock | 206.682 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-020791 · doc4.xml · nonDerivative · entry 1 WITTY ANDREW · CIK 0001711304 · EVP & CEO, Optum 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,605.752 F1 · shares: Represents dividend equivalents paid on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if such units do not vest. Read SEC document |
| March 14, 2019 Filed Mar 15, 2019 20:16 UTC |
WILENSKY GAIL RDirector
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 860 | $0.00 Strike: $28.10 | $0.00 |
DisclosureSEC source: 0001209191-19-019685 · doc4.xml · derivative · entry 6 WILENSKY GAIL R · CIK 0001018538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 860 shares Expires 2019-06-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 14, 2019 Filed Mar 15, 2019 20:16 UTC |
WILENSKY GAIL RDirector
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 5,000 | $0.00 Strike: $20.68 | $0.00 |
DisclosureSEC source: 0001209191-19-019685 · doc4.xml · derivative · entry 5 WILENSKY GAIL R · CIK 0001018538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2019-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 14, 2019 Filed Mar 15, 2019 20:16 UTC |
WILENSKY GAIL RDirector
|
SaleCommon Stock | 430 | $253.48 | $108,996.40 |
DisclosureSEC source: 0001209191-19-019685 · doc4.xml · nonDerivative · entry 4 WILENSKY GAIL R · CIK 0001018538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,656 Read SEC document |
| March 14, 2019 Filed Mar 15, 2019 20:16 UTC |
WILENSKY GAIL RDirector
|
Exercise / conversionCommon Stock | 860 | $28.10 | $24,166.00 |
DisclosureSEC source: 0001209191-19-019685 · doc4.xml · nonDerivative · entry 3 WILENSKY GAIL R · CIK 0001018538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,086 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 14, 2019 Filed Mar 15, 2019 20:16 UTC |
WILENSKY GAIL RDirector
|
SaleCommon Stock | 2,500 | $253.38 | $633,439.50 |
DisclosureSEC source: 0001209191-19-019685 · doc4.xml · nonDerivative · entry 2 WILENSKY GAIL R · CIK 0001018538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,226 F1 · price: This transaction was executed in multiple trades ranging from $253.368 to $253.38 per share. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the sales were effected. Read SEC document |
| March 14, 2019 Filed Mar 15, 2019 20:16 UTC |
WILENSKY GAIL RDirector
|
Exercise / conversionCommon Stock | 5,000 | $20.68 | $103,400.00 |
DisclosureSEC source: 0001209191-19-019685 · doc4.xml · nonDerivative · entry 1 WILENSKY GAIL R · CIK 0001018538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,726 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 12, 2019 Filed Mar 14, 2019 21:38 UTC |
BURKE RICHARD TDirector
|
SaleCommon Stock | 5,000 | $245.01 | $1,225,055.00 |
DisclosureSEC source: 0001209191-19-019515 · doc4.xml · nonDerivative · entry 1 BURKE RICHARD T · CIK 0000905023 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Partnership Disclosed balance after: 1,493,500 F1 · price: This transaction was executed in multiple trades ranging from $245.00 to $245.05 per share. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the sales were effected. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 22:35 UTC |
HEMSLEY STEPHEN JDirector · Executive Chair of the Board
|
GrantNon-Qualified Stock Options (right to buy) · Derivative | 64,130 | $0.00 Strike: $262.98 | $0.00 |
DisclosureSEC source: 0001209191-19-014625 · doc4.xml · derivative · entry 8 HEMSLEY STEPHEN J · CIK 0001180162 · Director · Executive Chair of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,130 Underlying: Common Stock · 64,130 shares Expires 2029-02-26 F4 · derivative.exercise_date: The stock options vest at a rate of 25% annually on February 26 from the years 2020 through 2023. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 22:35 UTC |
HEMSLEY STEPHEN JDirector · Executive Chair of the Board
|
GrantCommon Stock | 11,408 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-014625 · doc4.xml · nonDerivative · entry 3 HEMSLEY STEPHEN J · CIK 0001180162 · Director · Executive Chair of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,087,912.572 F3 · shares: The restricted stock units will vest at a rate of 25% annually on February 26 from the years 2020 through 2023. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 22:35 UTC |
HEMSLEY STEPHEN JDirector · Executive Chair of the Board
|
Tax withholdingCommon Stock | 28,766 | $262.98 | $7,564,882.68 |
DisclosureSEC source: 0001209191-19-014625 · doc4.xml · nonDerivative · entry 2 HEMSLEY STEPHEN J · CIK 0001180162 · Director · Executive Chair of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,076,504.572 F2 · shares: Represents the withholding of shares to satisfy tax obligations upon the settlement of Performance Share Awards for the performance period 2016-2018. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 22:35 UTC |
HEMSLEY STEPHEN JDirector · Executive Chair of the Board
|
GrantCommon Stock | 63,086 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-014625 · doc4.xml · nonDerivative · entry 1 HEMSLEY STEPHEN J · CIK 0001180162 · Director · Executive Chair of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,105,270.572 F1 · shares: Represents the settlement of Performance Share Awards for the performance period 2016-2018. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 22:36 UTC |
Nelson Steven HEVP & CEO, UnitedHealthcare
|
GrantNon-Qualified Stock Options (right to buy) · Derivative | 36,074 | $0.00 Strike: $262.98 | $0.00 |
DisclosureSEC source: 0001209191-19-014627 · doc4.xml · derivative · entry 4 Nelson Steven H · CIK 0001320490 · EVP & CEO, UnitedHealthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,074 Underlying: Common Stock · 36,074 shares Expires 2029-02-26 F5 · derivative.exercise_date: The stock options vest at a rate of 25% annually on February 26 from the years 2020 through 2023. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 22:36 UTC |
Nelson Steven HEVP & CEO, UnitedHealthcare
|
GrantCommon Stock | 6,417 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-014627 · doc4.xml · nonDerivative · entry 3 Nelson Steven H · CIK 0001320490 · EVP & CEO, UnitedHealthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,333.204 F3 · shares: The restricted stock units vest at a rate of 25% annually on February 26 from the years 2020 through 2023. F4 · balance_after: Amount does not include Performance Share Awards granted to the executive officer on February 26, 2019, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of Performance Shares that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of cumulative 3-year EPS and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of Performance Awards is 12,834. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 22:36 UTC |
Nelson Steven HEVP & CEO, UnitedHealthcare
|
Tax withholdingCommon Stock | 10,152 | $262.98 | $2,669,772.96 |
DisclosureSEC source: 0001209191-19-014627 · doc4.xml · nonDerivative · entry 2 Nelson Steven H · CIK 0001320490 · EVP & CEO, UnitedHealthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,916.204 F2 · shares: Represents the withholding of shares to satisfy tax obligations upon the settlement of Performance Share Awards for the performance period 2016-2018. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 22:36 UTC |
Nelson Steven HEVP & CEO, UnitedHealthcare
|
GrantCommon Stock | 22,266 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-014627 · doc4.xml · nonDerivative · entry 1 Nelson Steven H · CIK 0001320490 · EVP & CEO, UnitedHealthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,068.204 F1 · shares: Represents the settlement of Performance Share Awards for the performance period 2016-2018. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 22:37 UTC |
REX JOHN FEVP Chief Financial Officer
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 37,410 | $0.00 Strike: $262.98 | $0.00 |
DisclosureSEC source: 0001209191-19-014630 · doc4.xml · derivative · entry 4 REX JOHN F · CIK 0001676672 · EVP Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,410 Underlying: Common Stock · 37,410 shares Expires 2029-02-26 F5 · derivative.exercise_date: The stock options vest at a rate of 25% annually on February 26 from the years 2020 through 2023. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 22:37 UTC |
REX JOHN FEVP Chief Financial Officer
|
GrantCommon Stock | 6,655 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-014630 · doc4.xml · nonDerivative · entry 3 REX JOHN F · CIK 0001676672 · EVP Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,026.302 F3 · shares: The restricted stock units vest at a rate of 25% annually on February 26 from the years 2020 through 2023. F4 · balance_after: Amount does not include Performance Share Awards granted to the executive officer on February 26,2019, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of Performance Shares that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of cumulative 3-year EPS and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of Performance Share Awards is 13,309. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 22:37 UTC |
REX JOHN FEVP Chief Financial Officer
|
Tax withholdingCommon Stock | 8,300 | $262.98 | $2,182,734.00 |
DisclosureSEC source: 0001209191-19-014630 · doc4.xml · nonDerivative · entry 2 REX JOHN F · CIK 0001676672 · EVP Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,371.302 F2 · shares: Represents the withholding of shares to satisfy tax obligations upon the settlement of Performance Share Awards for the performance period 2016-2018. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 22:37 UTC |
REX JOHN FEVP Chief Financial Officer
|
GrantCommon Stock | 16,869 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-014630 · doc4.xml · nonDerivative · entry 1 REX JOHN F · CIK 0001676672 · EVP Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,671.302 F1 · shares: Represents the settlement of Performance Share Awards for the performance period 2016-2018. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 22:39 UTC |
ROOS THOMAS EChief Accounting Officer
|
GrantNon-Qualified Stock Options (right to buy) · Derivative | 18,171 | $0.00 Strike: $262.98 | $0.00 |
DisclosureSEC source: 0001209191-19-014633 · doc4.xml · derivative · entry 2 ROOS THOMAS E · CIK 0001651737 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,171 Underlying: Common Stock · 18,171 shares Expires 2029-02-26 F2 · derivative.exercise_date: The stock options vest at a rate of 25% annually on February 26 from the years 2020 through 2023. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 22:39 UTC |
ROOS THOMAS EChief Accounting Officer
|
GrantCommon Stock | 3,233 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-014633 · doc4.xml · nonDerivative · entry 1 ROOS THOMAS E · CIK 0001651737 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,828.667 F1 · shares: The restricted stock units vest at a rate of 25% annually on February 26 from the years 2020 through 2023. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 22:40 UTC |
SHORT MARIANNE DEVP & Chief Legal Officer
|
GrantNon-Qualified Stock Options (right to buy) · Derivative | 24,049 | $0.00 Strike: $262.98 | $0.00 |
DisclosureSEC source: 0001209191-19-014636 · doc4.xml · derivative · entry 4 SHORT MARIANNE D · CIK 0001565456 · EVP & Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,049 Underlying: Common Stock · 24,049 shares Expires 2029-02-26 F5 · derivative.exercise_date: The stock options vest at a rate of 25% annually on February 26 from the years 2020 through 2023. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 22:40 UTC |
SHORT MARIANNE DEVP & Chief Legal Officer
|
GrantCommon Stock | 4,278 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-014636 · doc4.xml · nonDerivative · entry 3 SHORT MARIANNE D · CIK 0001565456 · EVP & Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,933.163 F3 · shares: The restricted stock units vest at a rate of 25% annually on February 26 from the years 2020 through 2023. F4 · balance_after: Amount does not include Performance Share Awards granted to the executive officer on February 26, 2019, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of Performance Shares that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of cumulative 3-year EPS and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of Performance Shares is 8,556. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 22:40 UTC |
SHORT MARIANNE DEVP & Chief Legal Officer
|
Tax withholdingCommon Stock | 9,538 | $262.98 | $2,508,303.24 |
DisclosureSEC source: 0001209191-19-014636 · doc4.xml · nonDerivative · entry 2 SHORT MARIANNE D · CIK 0001565456 · EVP & Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,655.163 F2 · shares: Represents the withholding of shares to satisfy tax obligations upon the settlement of Performance Share Awards for the performance period 2016-2018. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 22:40 UTC |
SHORT MARIANNE DEVP & Chief Legal Officer
|
GrantCommon Stock | 20,916 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-014636 · doc4.xml · nonDerivative · entry 1 SHORT MARIANNE D · CIK 0001565456 · EVP & Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,193.163 F1 · shares: Represents the settlement of Performance Share Awards for the performance period 2016-2018. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 22:41 UTC |
WICHMANN DAVID SDirector · Chief Executive Officer
|
GrantNon-Qualified Stock Options (right to buy) · Derivative | 68,406 | $0.00 Strike: $262.98 | $0.00 |
DisclosureSEC source: 0001209191-19-014639 · doc4.xml · derivative · entry 5 WICHMANN DAVID S · CIK 0001268489 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,406 Underlying: Common Stock · 68,406 shares Expires 2029-02-26 F5 · derivative.exercise_date: The stock options vest at a rate of 25% annually on February 26 from the years 2020 through 2023. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 22:41 UTC |
WICHMANN DAVID SDirector · Chief Executive Officer
|
GrantCommon Stock | 12,169 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-014639 · doc4.xml · nonDerivative · entry 3 WICHMANN DAVID S · CIK 0001268489 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 884,244.521 F3 · shares: The restricted stock units will vest at a rate of 25% annually on February 26 from the years 2020 through 2023. F4 · balance_after: Amount does not include Performance Share Awards granted to the executive officer on February 26, 2019, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of Performance Shares that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of cumulative 3-year EPS and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of Performance Awards is 24,337. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 22:41 UTC |
WICHMANN DAVID SDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 21,910 | $262.98 | $5,761,891.80 |
DisclosureSEC source: 0001209191-19-014639 · doc4.xml · nonDerivative · entry 2 WICHMANN DAVID S · CIK 0001268489 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 872,075.521 F2 · shares: Represents the withholding of shares to satisfy tax obligations upon the settlement of Performance Share Awards for the performance period 2016-2018. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 22:41 UTC |
WICHMANN DAVID SDirector · Chief Executive Officer
|
GrantCommon Stock | 44,531 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-014639 · doc4.xml · nonDerivative · entry 1 WICHMANN DAVID S · CIK 0001268489 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 893,985.521 F1 · shares: Represents the settlement of Performance Share Awards for the performance period 2016-2018. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 22:42 UTC |
WILSON D ELLENEVP & Chief HR Officer
|
GrantNon-Qualified Stock Options (right to buy) · Derivative | 21,377 | $0.00 Strike: $262.98 | $0.00 |
DisclosureSEC source: 0001209191-19-014642 · doc4.xml · derivative · entry 4 WILSON D ELLEN · CIK 0001633390 · EVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,377 Underlying: Common Stock · 21,377 shares Expires 2029-02-26 F5 · derivative.exercise_date: The stock options vest at a rate of 25% annually on February 26 from the years 2020 through 2023. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 22:42 UTC |
WILSON D ELLENEVP & Chief HR Officer
|
GrantCommon Stock | 3,803 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-014642 · doc4.xml · nonDerivative · entry 3 WILSON D ELLEN · CIK 0001633390 · EVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,485.848 F3 · shares: The restricted stock units vest at a rate of 25% annually on February 26 from the years 2020 through 2023. F4 · balance_after: Amount does not include Performance Share Awards granted to the executive officer on February 26, 2019, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of Performance Shares that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of cumulative 3-year EPS and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of Performance Shares is 7,606. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 22:42 UTC |
WILSON D ELLENEVP & Chief HR Officer
|
Tax withholdingCommon Stock | 7,423 | $262.98 | $1,952,100.54 |
DisclosureSEC source: 0001209191-19-014642 · doc4.xml · nonDerivative · entry 2 WILSON D ELLEN · CIK 0001633390 · EVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,682.848 F2 · shares: Represents the withholding of shares to satisfy tax obligations upon the settlement of Performance Share Awards for the performance period 2016-2018. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 22:42 UTC |
WILSON D ELLENEVP & Chief HR Officer
|
GrantCommon Stock | 16,278 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-014642 · doc4.xml · nonDerivative · entry 1 WILSON D ELLEN · CIK 0001633390 · EVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,105.848 F1 · shares: Represents the settlement of Performance Share Awards for the performance period 2016-2018. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 22:43 UTC |
WITTY ANDREWEVP & CEO, Optum
|
GrantNon-Qualified Stock Options (right to buy) · Derivative | 50,770 | $0.00 Strike: $262.98 | $0.00 |
DisclosureSEC source: 0001209191-19-014645 · doc4.xml · derivative · entry 2 WITTY ANDREW · CIK 0001711304 · EVP & CEO, Optum 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,770 Underlying: Common Stock · 50,770 shares Expires 2029-02-26 F3 · derivative.exercise_date: The stock options vest at a rate of 25% annually on February 26 from the years 2020 through 2023. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 22:43 UTC |
WITTY ANDREWEVP & CEO, Optum
|
GrantCommon Stock | 9,032 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-014645 · doc4.xml · nonDerivative · entry 1 WITTY ANDREW · CIK 0001711304 · EVP & CEO, Optum 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,399.07 F1 · shares: The restricted stock units will vest at a rate of 25% annually on February 26 from the years 2020 through 2023. F2 · balance_after: Amount does not include Performance Share Awards granted to the executive officer on February 26, 2019, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of Performance Shares that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of cumulative 3-year EPS and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of Performance Awards is 18,063. Read SEC document |
| February 13, 2019 Filed Feb 14, 2019 23:10 UTC |
HEMSLEY STEPHEN JDirector · Executive Chair of the Board
|
Tax withholdingCommon Stock | 901 | $263.80 | $237,683.80 |
DisclosureSEC source: 0001209191-19-010394 · doc4.xml · nonDerivative · entry 1 HEMSLEY STEPHEN J · CIK 0001180162 · Director · Executive Chair of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,042,184.572 Read SEC document |
| February 13, 2019 Filed Feb 14, 2019 23:10 UTC |
Nelson Steven HEVP & CEO, UnitedHealthcare
|
Tax withholdingCommon Stock | 675 | $263.80 | $178,065.00 |
DisclosureSEC source: 0001209191-19-010396 · doc4.xml · nonDerivative · entry 1 Nelson Steven H · CIK 0001320490 · EVP & CEO, UnitedHealthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,802.204 Read SEC document |
| February 13, 2019 Filed Feb 14, 2019 23:12 UTC |
REX JOHN FEVP Chief Financial Officer
|
Tax withholdingCommon Stock | 688 | $263.80 | $181,494.40 |
DisclosureSEC source: 0001209191-19-010399 · doc4.xml · nonDerivative · entry 1 REX JOHN F · CIK 0001676672 · EVP Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,802.302 Read SEC document |
| February 13, 2019 Filed Feb 14, 2019 23:12 UTC |
ROOS THOMAS EChief Accounting Officer
|
Tax withholdingCommon Stock | 440 | $263.80 | $116,072.00 |
DisclosureSEC source: 0001209191-19-010401 · doc4.xml · nonDerivative · entry 1 ROOS THOMAS E · CIK 0001651737 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,595.667 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.